Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishenyangsui, also known as the Yishen Yangsui Recipe, is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at Wang Jing Hospital of the China Academy of Chinese Medical Sciences. It is specifically indicated for the treatment of cervical spondylotic myelopathy (CSM). The formula is based on the TCM theory of "tonifying the kidney and nourishing the marrow" to address the underlying pathology of spinal cord compression and neurological deficit. Clinical research, including long-term follow-up studies, has focused on evaluating its ability to improve clinical outcomes, assess the necessity of surgical intervention, and identify risk factors for reoperation in CSM patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yishenyangsui.